Top compounds associated with response to TIGD5


Feature Type Standardized
Nominal ANOVA
mRNA RITA CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA ATRA CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.15 7e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA masitinib GDSC1000 pan-cancer AAC 0.11 0.0003
mRNA XL-184 GDSC1000 pan-cancer AAC 0.12 0.0005
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0005
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.096 0.0005
Download CSV